Phase II Single Arm Study of CABozantinib in Non-Small Cell Lung Cancer Patients with MET Deregulation (CABinMET)

被引：5
|
作者：
D'Arcangelo, M. [1 ]
Tassinari, D. [2 ]
De Marinis, F. [3 ]
Delmonte, A. [4 ]
Galetta, D. [5 ]
Cecere, F. [6 ]
Pilotto, S. [7 ]
Zanelli, F. [8 ]
Bonanno, L. [9 ]
Landi, L. [1 ]
D'Inca, F. [10 ]
Cappuzzo, F. [1 ]
机构：
[1] Azienda Usl Romagna, Oncol & Hematol, Ravenna, Italy
[2] Ausl Romagna, Rimini, Italy
[3] Ist Europeo Oncol Ircss, Milan, Italy
[4] Ist Sci Romagnolo Studio & Cura Tumori Irst, Meldola, Italy
[5] Clin Canc Ctr Giovanni Paolo Ii, Thorac Med Oncol Unit, Bari, Italy
[6] Ist Nazl Tumori Regina Elena, Rome, Italy
[7] Aou Integrata Verona, Verona, Italy
[8] Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
[9] Ist Oncol Veneto, Padua, Italy
[10] Fdn Ric Traslaz, Rome, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
NSCLC; MET; cabozantinib;
D O I：
10.1016/j.jtho.2019.08.1359
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-15
引用
收藏
页码：S644 / S644
页数：1
相关论文
共 50 条
  • [31] Sorafenib and metformin in pretreated patients with stage IV non-small cell lung cancer with a KRAS imitation: A multicenter single arm phase II study.
    Mellema, Wouter Willem
    Burgers, Sjaak A.
    Groen, Harry J. M.
    Dingemans, Anne-Marie C.
    Thunnlssen, Erik
    Heideman, Danielle
    Smit, Egbert F.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Anlotinib combination with docetaxol for patients with previously treated advanced non-small cell lung cancer: A phase II, single-arm trial
    Chen, X.
    Shen, J.
    Li, X.
    Yang, S.
    Xia, B.
    Wang, B.
    Wang, J.
    Zheng, S.
    Zhao, P.
    Ma, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S877 - S877
  • [33] Anlotinib combined with radiotherapy in locally advanced non-small cell lung cancer (LANSCLC): A prospective, single-arm, phase II study
    Ning, P.
    Chang, H.
    Zhang, J.
    Rong, P.
    Liu, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S944 - S944
  • [34] Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study
    Yang, Jin-Ji
    Zhang, Yan
    Wu, Lin
    Hu, Jie
    Wang, Zhe-Hai
    Chen, Jing-Hua
    Fan, Yun
    Lin, Gen
    Wang, Qi-Ming
    Yao, Yu
    Zhao, Jun
    Chen, Yuan
    Fang, Jian
    Song, Yong
    Zhang, Wei
    Cheng, Ying
    Guo, Ren-Hua
    Li, Xing-Ya
    Shi, He-Peng
    Xue, Wei-Zhe
    Han, Di
    Zhang, Pei-Long
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (31)
  • [35] Tumor heterogeneity with novel MET fusion showed different response to cabozantinib in non-small cell lung cancer
    Yu, Lanfang
    Wu, Yinfang
    Zhang, Biyan
    Ma, Ruobing
    Yan, Na
    Mou, Haibo
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (08): : 10983 - 10986
  • [36] Results of a phase II study of single-agent sunitinib in elderly non-small cell lung cancer patients.
    Reynolds, C.
    Spira, A. I.
    Gluck, W. L.
    Pluenneke, R. E.
    Boehm, K. A.
    Zhan, F.
    Asmar, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] PHASE-II STUDY OF UFT IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG-CANCER
    KEICHO, N
    SAIJO, N
    SHINKAI, T
    EGUCHI, K
    SASAKI, Y
    TAMURA, T
    SAKURAI, M
    SANO, T
    HOSHI, A
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1986, 16 (02) : 143 - 146
  • [38] A phase II study of vorolanib in combination with toripalimab in patients with non-small cell lung cancer.
    Zhao, Jun
    Li, Jianjie
    Chen, Hanxiao
    Yang, Xue
    Zhong, Jia
    Zhuo, Minglei
    Jia, Bo
    An, Tongtong
    Wu, Meina
    Wang, Ziping
    Ding, Lieming
    Mao, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Phase II Study of Docetaxel and Carboplatin in Elderly Patients with Advanced Non-small Cell Lung Cancer
    Yoshimura, Naruo
    Kudoh, Shinzoh
    Kimura, Tatsuo
    Mitsuoka, Shigeki
    Kyoh, Shigenoir
    Tochino, Yoshihiro
    Asai, Kazuhisa
    Kodama, Toyoki
    Ichimaru, Yukikazu
    Yana, Takashi
    Hirata, Kazuto
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (03) : 371 - 375
  • [40] Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
    Gatzemeier, U
    Shepherd, FA
    LeChevalier, T
    Weynants, P
    Cottier, B
    Groen, HJM
    Rosso, R
    Mattson, K
    CortesFunes, H
    Tonato, M
    Burkes, RL
    Gottfried, M
    Voi, M
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (02) : 243 - 248
12345